These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. L-Serine Treatment is Associated with Improvements in Behavior, EEG, and Seizure Frequency in Individuals with GRIN-Related Disorders Due to Null Variants. Krey I; von Spiczak S; Johannesen KM; Hikel C; Kurlemann G; Muhle H; Beysen D; Dietel T; Møller RS; Lemke JR; Syrbe S Neurotherapeutics; 2022 Jan; 19(1):334-341. PubMed ID: 34997442 [TBL] [Abstract][Full Text] [Related]
12. GRIN2B gain of function mutations are sensitive to radiprodil, a negative allosteric modulator of GluN2B-containing NMDA receptors. Mullier B; Wolff C; Sands ZA; Ghisdal P; Muglia P; Kaminski RM; André VM Neuropharmacology; 2017 Sep; 123():322-331. PubMed ID: 28533163 [TBL] [Abstract][Full Text] [Related]
13. Disease-Associated Variants in GRIN1, GRIN2A and GRIN2B genes: Insights into NMDA Receptor Structure, Function, and Pathophysiology. Korinek M; Candelas Serra M; Abdel Rahman F; Dobrovolski M; Kuchtiak V; Abramova V; Fili K; Tomovic E; Hrcka Krausova B; Krusek J; Cerny J; Vyklicky L; Balik A; Smejkalova T Physiol Res; 2024 May; 73(Suppl 1):S413-S434. PubMed ID: 38836461 [TBL] [Abstract][Full Text] [Related]
14. Opportunities for Precision Treatment of Han W; Yuan H; Allen JP; Kim S; Shaulsky GH; Perszyk RE; Traynelis SF; Myers SJ J Pharmacol Exp Ther; 2022 Apr; 381(1):54-66. PubMed ID: 35110392 [TBL] [Abstract][Full Text] [Related]
16. L-serine treatment in patients with GRIN-related encephalopathy: a phase 2A, non-randomized study. Juliá-Palacios N; Olivella M; Sigatullina Bondarenko M; Ibáñez-Micó S; Muñoz-Cabello B; Alonso-Luengo O; Soto-Insuga V; García-Navas D; Cuesta-Herraiz L; Andreo-Lillo P; Aguilera-Albesa S; Hedrera-Fernández A; González Alguacil E; Sánchez-Carpintero R; Martín Del Valle F; Jiménez González E; Cean Cabrera L; Medina-Rivera I; Perez-Ordoñez M; Colomé R; Lopez L; Engracia Cazorla M; Fornaguera M; Ormazabal A; Alonso-Colmenero I; Illescas KS; Balsells-Mejía S; Mari-Vico R; Duffo Viñas M; Cappuccio G; Terrone G; Romano R; Manti F; Mastrangelo M; Alfonsi C; de Siqueira Barros B; Nizon M; Gjerulfsen CE; Muro VL; Karall D; Zeiner F; Masnada S; Peterlongo I; Oyarzábal A; Santos-Gómez A; Altafaj X; García-Cazorla Á Brain; 2024 May; 147(5):1653-1666. PubMed ID: 38380699 [TBL] [Abstract][Full Text] [Related]
17. Functional assessment of triheteromeric NMDA receptors containing a human variant associated with epilepsy. Marwick KFM; Hansen KB; Skehel PA; Hardingham GE; Wyllie DJA J Physiol; 2019 Mar; 597(6):1691-1704. PubMed ID: 30604514 [TBL] [Abstract][Full Text] [Related]
18. Mutations in GRIN2A and GRIN2B encoding regulatory subunits of NMDA receptors cause variable neurodevelopmental phenotypes. Endele S; Rosenberger G; Geider K; Popp B; Tamer C; Stefanova I; Milh M; Kortüm F; Fritsch A; Pientka FK; Hellenbroich Y; Kalscheuer VM; Kohlhase J; Moog U; Rappold G; Rauch A; Ropers HH; von Spiczak S; Tönnies H; Villeneuve N; Villard L; Zabel B; Zenker M; Laube B; Reis A; Wieczorek D; Van Maldergem L; Kutsche K Nat Genet; 2010 Nov; 42(11):1021-6. PubMed ID: 20890276 [TBL] [Abstract][Full Text] [Related]
19. GRIN2A-related epilepsy and speech disorders: A comprehensive overview with a focus on the role of precision therapeutics. Samanta D Epilepsy Res; 2023 Jan; 189():107065. PubMed ID: 36516565 [TBL] [Abstract][Full Text] [Related]